# DEKA Research & Development acquires assets from Diatech Diabetes

DEKA Research & Development acquired core assets and intellectual property from Diatech Diabetes, including the SmartFusion infusion monitoring software. The deal also includes the hiring of select leadership from Diatech.

- Type: Acquisition
- Announced: 2025-10-07
- Where: United States
- Status: completed
- Products: SmartFusion infusion monitoring software, insulin pump technology
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [DEKA Research & Development](https://endata.com/companies/87705.md) (acquirer)
- [Diatech Diabetes](https://endata.com/companies/87706.md) (target)

## Sources

- [drugdeliverybusiness.com](https://www.drugdeliverybusiness.com/deka-acquires-assets-ip-diatech-diabetes/), 2025-10-07: "We are excited to bring Diatech's technology and team into DEKA."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.